397 related articles for article (PubMed ID: 27518087)
1. CD38 Knockout Mice Show Significant Protection Against Ischemic Brain Damage Despite High Level Poly-ADP-Ribosylation.
Long A; Park JH; Klimova N; Fowler C; Loane DJ; Kristian T
Neurochem Res; 2017 Jan; 42(1):283-293. PubMed ID: 27518087
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) accumulation and enhancement of postischemic brain damage in 110-kDa poly(ADP-ribose) glycohydrolase null mice.
Cozzi A; Cipriani G; Fossati S; Faraco G; Formentini L; Min W; Cortes U; Wang ZQ; Moroni F; Chiarugi A
J Cereb Blood Flow Metab; 2006 May; 26(5):684-95. PubMed ID: 16177811
[TBL] [Abstract][Full Text] [Related]
3. Activation of cell death mediated by apoptosis-inducing factor due to the absence of poly(ADP-ribose) glycohydrolase.
Zhou Y; Feng X; Koh DW
Biochemistry; 2011 Apr; 50(14):2850-9. PubMed ID: 21366272
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.
Park JH; Long A; Owens K; Kristian T
Neurobiol Dis; 2016 Nov; 95():102-10. PubMed ID: 27425894
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death.
Ying W; Sevigny MB; Chen Y; Swanson RA
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12227-32. PubMed ID: 11593040
[TBL] [Abstract][Full Text] [Related]
6. CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins.
Krebs C; Adriouch S; Braasch F; Koestner W; Leiter EH; Seman M; Lund FE; Oppenheimer N; Haag F; Koch-Nolte F
J Immunol; 2005 Mar; 174(6):3298-305. PubMed ID: 15749861
[TBL] [Abstract][Full Text] [Related]
7. Benefits in cardiac function by CD38 suppression: Improvement in NAD
Agorrody G; Peclat TR; Peluso G; Gonano LA; Santos L; van Schooten W; Chini CCS; Escande C; Chini EN; Contreras P
J Mol Cell Cardiol; 2022 May; 166():11-22. PubMed ID: 35114253
[TBL] [Abstract][Full Text] [Related]
8. Identification of ADP-ribosylation sites of CD38 mutants by precursor ion scanning mass spectrometry.
Jiang H; Sherwood R; Zhang S; Zhu X; Liu Q; Graeff R; Kriksunov IA; Lee HC; Hao Q; Lin H
Anal Biochem; 2013 Feb; 433(2):218-26. PubMed ID: 23123429
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) metabolism in brain and its role in ischemia pathology.
Strosznajder RP; Czubowicz K; Jesko H; Strosznajder JB
Mol Neurobiol; 2010 Jun; 41(2-3):187-96. PubMed ID: 20411356
[TBL] [Abstract][Full Text] [Related]
10. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
[TBL] [Abstract][Full Text] [Related]
11. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
Mashimo M; Bu X; Aoyama K; Kato J; Ishiwata-Endo H; Stevens LA; Kasamatsu A; Wolfe LA; Toro C; Adams D; Markello T; Gahl WA; Moss J
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830864
[TBL] [Abstract][Full Text] [Related]
12. Functional Role of ADP-Ribosyl-Acceptor Hydrolase 3 in poly(ADP-Ribose) Polymerase-1 Response to Oxidative Stress.
Mashimo M; Moss J
Curr Protein Pept Sci; 2016; 17(7):633-640. PubMed ID: 27090906
[TBL] [Abstract][Full Text] [Related]
13. ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose).
Niere M; Mashimo M; Agledal L; Dölle C; Kasamatsu A; Kato J; Moss J; Ziegler M
J Biol Chem; 2012 May; 287(20):16088-102. PubMed ID: 22433848
[TBL] [Abstract][Full Text] [Related]
14. New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase.
Tanuma S; Sato A; Oyama T; Yoshimori A; Abe H; Uchiumi F
Curr Protein Pept Sci; 2016; 17(7):668-682. PubMed ID: 27817743
[TBL] [Abstract][Full Text] [Related]
15. CD38-dependent ADP-ribosyl cyclase activity in developing and adult mouse brain.
Ceni C; Pochon N; Brun V; Muller-Steffner H; Andrieux A; Grunwald D; Schuber F; De Waard M; Lund F; Villaz M; Moutin MJ
Biochem J; 2003 Feb; 370(Pt 1):175-83. PubMed ID: 12403647
[TBL] [Abstract][Full Text] [Related]
16. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
17. Remission of social behavior impairment by oral administration of a precursor of NAD in CD157, but not in CD38, knockout mice.
Gerasimenko M; Higashida H
Front Immunol; 2023; 14():1166609. PubMed ID: 37215105
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an intracellular ADP-ribosyl cyclase/NAD+-glycohydrolase in brain from CD38-deficient mice.
Ceni C; Muller-Steffner H; Lund F; Pochon N; Schweitzer A; De Waard M; Schuber F; Villaz M; Moutin MJ
J Biol Chem; 2003 Oct; 278(42):40670-8. PubMed ID: 12909645
[TBL] [Abstract][Full Text] [Related]
19. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
Virág L
Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
[TBL] [Abstract][Full Text] [Related]
20. Structure and function of the ARH family of ADP-ribosyl-acceptor hydrolases.
Mashimo M; Kato J; Moss J
DNA Repair (Amst); 2014 Nov; 23():88-94. PubMed ID: 24746921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
